Aralez Pharmaceuticals Inc (ARZ.TO) Key Developments | Reuters.com
Edition:
United States

Aralez Pharmaceuticals Inc (ARZ.TO)

ARZ.TO on Toronto Stock Exchange

4.40CAD
2:00pm EDT
Change (% chg)

$0.02 (+0.46%)
Prev Close
$4.38
Open
$4.44
Day's High
$4.44
Day's Low
$4.34
Volume
1,743
Avg. Vol
14,927
52-wk High
$8.45
52-wk Low
$0.99

Latest Key Developments (Source: Significant Developments)

Aralez posts Q1 loss of $0.73/share
Tuesday, 10 May 2016 07:29am EDT 

Aralez Pharmaceuticals Inc : Aralez reports first quarter 2016 financial results . Qtrly GAAP loss per share $0.73 .Total net revenues for three months ended March 31, 2016 were about $8.1 million compared to $4.4 million.  Full Article

Aralez Pharmaceuticals receives Health Canada approval For BLEXTEN
Monday, 25 Apr 2016 07:00am EDT 

Aralez Pharmaceuticals:Says Health Canada approval of BLEXTEN for treatment of symptoms of seasonal allergic rhinitis and chronic spontaneous urticaria.BLEXTEN will be distributed in Canada by Tribute Pharmaceuticals Canada Inc, also a subsidiary of Company.  Full Article

BRIEF-Aralez posts Q1 loss of $0.73/share

* Total net revenues for three months ended March 31, 2016 were about $8.1 million compared to $4.4 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

No consensus analysis data available.